Effect of a Multi-strain Probiotic on Recurrent Vulvovaginal Candidiasis

计划入组 126 人 · 首次发布于 2024 年 6 月 28 日

Prevention of Recurrent Vulvovaginal Candidiasis With Lactibiane Candisis 5M®

计划入组 134 人 · 首次发布于 2009 年 6 月 8 日

Fluconazol Versus Medical Honey in the Treatment of Recurrent Vulvovaginal Candidiasis

计划入组 252 人 · 首次发布于 2020 年 11 月 12 日

Ibrexafungerp(Brexafemme)

C₄₄H₆₇N₅O₄ · Rx

Oteseconazole(Vivjoa)

C₂₃H₁₆F₇N₅O₂ · Rx

Recurrent respiratory papillomatosis(BlueSphere)

Scynexis

United States

Axcella Health

United States

Astria Therapeutics Inc

United States

pH-D Feminine Health Initiates First FDA-Cleared Phase 3 Trial for Boric Acid Suppositories in Yeast Infections

SCYNEXIS Receives FDA Fast Track and QIDP Designations for SCY-247 Antifungal Therapy

Mycovia Pharmaceuticals Initiates Phase 2 Trial of Oteseconazole for Cryptococcal Meningitis